IL273482A - A process for the preparation of a soluble platelet fraction, a soluble platelet fraction and its use for the treatment of disorders of the central nervous system - Google Patents

A process for the preparation of a soluble platelet fraction, a soluble platelet fraction and its use for the treatment of disorders of the central nervous system

Info

Publication number
IL273482A
IL273482A IL273482A IL27348220A IL273482A IL 273482 A IL273482 A IL 273482A IL 273482 A IL273482 A IL 273482A IL 27348220 A IL27348220 A IL 27348220A IL 273482 A IL273482 A IL 273482A
Authority
IL
Israel
Prior art keywords
platelet lysate
lysate fraction
preparing
nervous system
central nervous
Prior art date
Application number
IL273482A
Other languages
English (en)
Hebrew (he)
Original Assignee
Inst Nat Sante Rech Med
Univ Taipei Medical
Univ Du Littoral Cote Dopale
Centre Hospitalier Regional Et Univ De Lille Chru
Univ Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Univ Taipei Medical, Univ Du Littoral Cote Dopale, Centre Hospitalier Regional Et Univ De Lille Chru, Univ Lille filed Critical Inst Nat Sante Rech Med
Publication of IL273482A publication Critical patent/IL273482A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL273482A 2017-09-27 2020-03-22 A process for the preparation of a soluble platelet fraction, a soluble platelet fraction and its use for the treatment of disorders of the central nervous system IL273482A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17306284 2017-09-27
PCT/EP2018/076244 WO2019063683A1 (en) 2017-09-27 2018-09-27 PROCESS FOR THE PREPARATION OF PLATELET LYSATE FRACTION, PLATELET LYSATE FRACTION AND USE THEREOF FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Publications (1)

Publication Number Publication Date
IL273482A true IL273482A (en) 2020-05-31

Family

ID=60083230

Family Applications (1)

Application Number Title Priority Date Filing Date
IL273482A IL273482A (en) 2017-09-27 2020-03-22 A process for the preparation of a soluble platelet fraction, a soluble platelet fraction and its use for the treatment of disorders of the central nervous system

Country Status (11)

Country Link
US (1) US20230135837A1 (enExample)
EP (1) EP3687554A1 (enExample)
JP (1) JP2020535163A (enExample)
CN (1) CN111107857A (enExample)
AU (1) AU2018343875A1 (enExample)
BR (1) BR112020006316A2 (enExample)
CA (1) CA3076858A1 (enExample)
IL (1) IL273482A (enExample)
RU (1) RU2020112898A (enExample)
TW (1) TW201914595A (enExample)
WO (1) WO2019063683A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012275562B2 (en) * 2011-06-27 2016-10-20 Children's Healthcare Of Atlanta, Inc. Compositions, uses, and preparation of platelet lysates
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
US20210236556A1 (en) * 2020-02-03 2021-08-05 Oklahoma Blood Institute Preparation of human platelet lysate (hpl) from refrigerated whole blood platelets
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4815063B2 (ja) * 2001-04-13 2011-11-16 きみ子 室伏 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤
SE528214C2 (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
CA2672524C (en) * 2006-12-14 2016-08-23 Neuronova Ab Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
WO2015123778A1 (en) * 2014-02-20 2015-08-27 Polyvalor, Limited Partnership Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections
EP3143130B1 (en) * 2014-05-16 2024-03-06 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells

Also Published As

Publication number Publication date
BR112020006316A2 (pt) 2020-09-24
CA3076858A1 (en) 2019-04-04
EP3687554A1 (en) 2020-08-05
CN111107857A (zh) 2020-05-05
AU2018343875A1 (en) 2020-04-16
RU2020112898A (ru) 2021-10-04
WO2019063683A1 (en) 2019-04-04
TW201914595A (zh) 2019-04-16
US20230135837A1 (en) 2023-05-04
JP2020535163A (ja) 2020-12-03

Similar Documents

Publication Publication Date Title
HRP20210518T1 (hr) Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava
IL267082A (en) Systems and methods for the treatment of neurological disorders
HUE049014T2 (hu) Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
HUE051488T2 (hu) Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
IL277658A (en) Dehydrated compounds of dihydro-4H-pyrazolo [5, 1, -C] [1, 4] oxazinyl and their analogues for the treatment of CNS disorders
IL271436A (en) A process for the preparation of the Agora human platelet-dissolving plate, the Agora human platelet-dissolving plate and its use in the treatment of neurological disorders
IL267818A (en) Methods for treating neurological disorders
IL273482A (en) A process for the preparation of a soluble platelet fraction, a soluble platelet fraction and its use for the treatment of disorders of the central nervous system
IL256350A (en) Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
IL275654A (en) Methods of treating CASTOR-related disorders
SG10201913400QA (en) Methods for treating lung disorders
ZA201902111B (en) Substituted pyrido[3,4¿b]indoles for the treatment of cartilage disorders
GB2550399B (en) A novel form of sulfentrazone, a process for its preparation and use the same
EP3573641A4 (en) TREATMENT METHODS FOR DISORDERS ASSOCIATED WITH ANGIOGENESIS AND NEOVASCULARIZATION
PL3432895T3 (pl) Lizat osadu płytek krwi do stosowania w leczeniu zaburzeń neurologicznych
EP3347011A4 (en) MUSCARIN COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGEN DISORDERS OF THE CENTRAL NERVOUS SYSTEM
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
LT3423440T (lt) 5-metil-6-fenil-4,5-dihidro-2h-piridazin-3-ono dariniai, skirti smegenų navikų gydymui
ZA201700037B (en) Compounds for the treatment of seizures and other central nervous system disorders and conditions
GB201700502D0 (en) Treatment of tumours of the central nervous system
HK40025989A (en) Methods of treating neuropsychiatric disorders
GB201602011D0 (en) Treating skin disorders
AU2014900627A0 (en) Modulation of diseases of the central nervous system and related disorders